| 82.88 Delayed Data As of 3:59pm ET |  +1.08 / +1.32%Today’s Change | 31.55 Today|||52-Week Range 84.97 | +23.28% Year-to-Date |
| Frontrunning: March 5 Mar 05 / Investing Channel | China Biologic Products CBPO) Falls: Stock Goes Down 6% - Tale of the Tape Feb 25 / Zacks.com |
| Previous close | 81.80 |
| Today’s open | 81.80 |
| Day’s range | 81.42 - 84.97 |
| Volume | 222,351 |
| Average volume (3 months) | 81,155 |
| Market cap | $2.0B |
| Dividend yield | -- |
| Earnings growth (last year) | +18.50% |
| Earnings growth (this year) | +32.75% |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | +10.03% |
| P/E ratio | 31.8 |
| Price/Sales | 3.75 |
| Price/Book | 8.90 |
| Today’s change | Today’s % change | |
|---|---|---|
| INSYINSYS Therapeutics I... | +0.08 | +0.14% |
| ANACAnacor Pharmaceutica... | +0.36 | +0.77% |
| RAREUltragenyx Pharmaceu... | +0.03 | +0.05% |
| MDCOMedicines Co | -0.86 | -2.90% |
| Next reporting date | May 5, 2015 |
| EPS forecast (this quarter) | $0.88 |
| Annual revenue (last year) | $203.4M |
| Annual profit (last year) | $54.1M |
| Net profit margin | 26.63% |
Sector Health Technology |
Industry Biotechnology |
Executive Chairman, President & CEO David Xiaoying Gao |
CFO, Treasurer & Vice President-Compliance Ming Yang |
Corporate headquarters Beijing, Beijing |
